Dashboard
Manage Tickers

BIOVFSwedish Orphan Biovitrum AB...


$ 0.97 (3.1 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 32.25
-- x --
-- x --
-- - --
$ 18.58 - $ 32.25
1,600
na
nm
$ 0.40
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

apellis-pharmaceuticals-pegcetacoplan-meets-primary-goal-in-late-stage-study-in-patients-with-rare-kidney-diseases
Apellis Pharmaceuticals' Pegcetacoplan Mee...
08/08/2024 16:53:31

Swedish Orphan Biovitrum and Apellis Pharmaceuticals released topline results from the Phase 3 VALIANT study of pegcetacoplan f...

pfizer-sanofis-respiratory-syncytial-virus-products-faces-insurance-and-logistical-hurdles-to-protect-infants
Pfizer, Sanofi's Respiratory Syncytial Vir...
10/16/2023 16:16:55

As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) v...

Core News & Articles
Sanofi, Sobi Earlier Announced ALTIVIIIO L...
06/26/2023 00:19:27

Pivotal data from the Phase 3 XTEND-Kids study evaluating ALTUVIIIOTM [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion ...

unanimous-support-for-astrazeneca-and-sanofis-nirsevimab-next-generation-rsv-treatment-on-the-horizon
Unanimous Support for AstraZeneca and Sano...
06/09/2023 12:07:06

The FDA's Antimicrobial Drugs Advisory Committee has voted unanimously 21 to 0 that AstraZeneca plc (NASDAQ: AZN) and Sanof...

apellis-pharma-flunks-on-primary-secondary-endpoints-in-amyotrophic-lateral-sclerosis-study
Apellis Pharma Flunks On Primary, Secondar...
05/25/2023 17:14:44

european-swedish-orphan-biovitrum-to-acquire-cti-biopharma-for-17b
European Swedish Orphan Biovitrum To Acqui...
05/10/2023 11:47:38

Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock...

selecta-sobis-chronic-refractory-gout-program-meets-primary-goal-us-submission-expected-next-year
Selecta, SOBI's Chronic Refractory Gout Pr...
03/21/2023 13:48:29

veru-stock-could-retrace-weeks-45-gain-as-fda-panel-votes-against-covid-19-drug
Veru Stock Could Retrace Week's 45% Gain A...
11/10/2022 06:40:29

Veru Inc.

europe-approves-astrazeneca-sanofi-partnered-antibody-to-prevent-rsv-infection-in-infants
Europe Approves AstraZeneca-Sanofi Partner...
11/04/2022 11:37:57

sanofis-hemophilia-candidate-goes-under-priority-fda-review
Sanofi's Hemophilia Candidate Goes Under P...
08/30/2022 10:46:09

the-daily-biotech-pulse-europe-approves-second-round-of-booster-doses-of-mrna-covid-19-vaccines-perrigo-seeks-approval-for-first-otc-birth-control-pill-macrogenics-closes-head--cancer-study-after-patient-death
The Daily Biotech Pulse: Europe Approves S...
07/11/2022 12:55:03

Here's a roundup of top developments in the biotech space over the last 24 hours:

sobi-sanofi-partnered-hemophilia-therapy-shows-superior-bleed-protection-than-prior-prophylaxis
SOBI-Sanofi Partnered Hemophilia Therapy S...
07/11/2022 11:02:11

the-daily-biotech-pulse-pfizer-inks-pact-with-africa-for-covid-19-pills-emergent-bio--ridgeback-to-increase-access-to-ebola-treatment-adc-therapeutics--sobi-in-european-pact-for-lymphoma-drug
The Daily Biotech Pulse: Pfizer Inks Pact ...
07/08/2022 12:19:02

Here's a roundup of top developments in the biotech space over the last 24 hours:

adc-therapeutics-sobi-ink-european-licensing-pact-for-lymphoma-drug
ADC Therapeutics, Sobi Ink European Licens...
07/08/2022 11:20:53

sanofi-sobi-hemophilia-candidate-aces-late-stage-study-in-pretreated-patients
Sanofi-SOBI Hemophilia Candidate Aces Late...
03/09/2022 11:38:55

Swedish Orphan Biovitrum AB (OTC: BIOVF) and Sanofi SA (NASDAQ: SNY) have announced topline results from the XTEND-1 phase 3 st...

apellis---sobis-pegcetacoplan-wins-european-approval-for-rare-blood-disorder
Apellis - Sobi's Pegcetacoplan Wins Europe...
12/15/2021 15:14:12

astrazeneca-blocks-sobis-8b-buyout-advent-withdraws-the-bid---report
AstraZeneca Blocks SOBI's $8B Buyout, Adve...
12/03/2021 11:50:26

AstraZeneca Plc (NASDAQ: AZN) blocked an $8 billion takeover of Swedish Orphan Biovitrum AB (OTC: BIOVF) by withholding its 8% ...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
02/24/2021 15:07:15

 

Core News & Articles
Barclays Downgrades Swedish Orphan Biovitr...
02/24/2021 13:23:14

Barclays analyst Rosie Turner downgrades Swedish Orphan Biovitrum (OTC:BIOVF) from Overweight to Equal-Weight.

Core News & Articles
Sobi and Selecta Announce Closing of Previ...
07/28/2020 10:23:00

Swedish Orphan Biovitrum AB (OTC: BIOVF) today announced that the strategic licensing agreement with Selecta Biosciences, Inc.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION